Literature DB >> 24255771

Cytokeratin-based CTC counting unrelated to clinical follow up.

Ludmilla Thomé Domingos Chinen1, Fernanda Machado de Carvalho, Bruna Maria Malagoli Rocha, Caroline Motta Aguiar, Emne Ali Abdallah, Daniel Campanha, Natália Breve Mingues, Thiago Bueno de Oliveira, Macello Sampaio Maciel, Gustavo Marchioro Cervantes, Aldo L A Dettino, Fernando Augusto Soares, Patrizia Paterlini-Bréchot, Marcello Ferretti Fanelli.   

Abstract

BACKGROUND: Circulating tumor cells (CTCs) have been reported to be a relevant prognostic biomarker in metastatic patients. However, their clinical use and impact is still under debate. We have thus comparatively and kinetically assessed two CTC detection methods according to the patient's clinical follow up.
METHODS: CTC counting and characterization were repeatedly performed during follow up in a patient with metastatic undifferentiated non-small cell lung cancer by using cytokeratin (CK)-dependent immunomagnetic separation (Miltenyi) and CK-independent, size-based isolation [isolation by size of tumor cells (ISET)] (Rarecells).
RESULTS: Comparison between the two methods showed a parallel increase of CTC detected by ISET and worsening of the clinical status, while CK-dependent CTC numbers were decreasing, misleadingly suggesting a response to treatment. ISET results were in agreement with the clinical follow up showing Circulating tumor microemboli (CTM) and CTC expressing a mesenchymal marker with absence of epithelial markers.
CONCLUSIONS: This case report study shows the interest of a comparative and kinetic analysis of different methods for CTCs detection combined with their evaluation according to the clinical follow up. Our results should open up an area for future research and validation in larger clinical cohorts.

Entities:  

Keywords:  Circulating tumor cells (CTCs); circulating tumor microemboli (CTM); immunomagnetic separation; isolation by size of tumor cells (ISET); lung cancer

Year:  2013        PMID: 24255771      PMCID: PMC3815714          DOI: 10.3978/j.issn.2072-1439.2013.09.18

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway.

Authors:  Jianfei Qi; Ning Chen; Junfu Wang; Chi-Hung Siu
Journal:  Mol Biol Cell       Date:  2005-06-29       Impact factor: 4.138

Review 3.  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.

Authors:  Jason J Christiansen; Ayyappan K Rajasekaran
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

4.  Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method.

Authors:  V Hofman; E Long; M Ilie; C Bonnetaud; J M Vignaud; J F Fléjou; S Lantuejoul; E Piaton; N Mourad; C Butori; E Selva; C H Marquette; M Poudenx; S Sibon; S Kelhef; N Vénissac; J P Jais; J Mouroux; T J Molina; P Vielh; P Hofman
Journal:  Cytopathology       Date:  2011-01-06       Impact factor: 2.073

Review 5.  Molecular mechanisms of metastasis in breast cancer--clinical applications.

Authors:  Michal Mego; Sendurai A Mani; Massimo Cristofanilli
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

6.  Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

Authors:  Matthew G Krebs; Jian-Mei Hou; Robert Sloane; Lee Lancashire; Lynsey Priest; Daisuke Nonaka; Tim H Ward; Alison Backen; Glen Clack; Andrew Hughes; Malcolm Ranson; Fiona H Blackhall; Caroline Dive
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

Review 7.  Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression.

Authors:  Georgia Agiostratidou; James Hulit; Greg R Phillips; Rachel B Hazan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.

Authors:  L Khoja; A Backen; R Sloane; L Menasce; D Ryder; M Krebs; R Board; G Clack; A Hughes; F Blackhall; J W Valle; C Dive
Journal:  Br J Cancer       Date:  2011-12-20       Impact factor: 7.640

Review 10.  Minimal residual disease and circulating tumor cells in breast cancer.

Authors:  Michail Ignatiadis; Monica Reinholz
Journal:  Breast Cancer Res       Date:  2011-10-25       Impact factor: 6.466

View more
  21 in total

1.  Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer.

Authors:  Yang-Yang Chen; Guo-Bin Xu
Journal:  Med Oncol       Date:  2014-11-01       Impact factor: 3.064

2.  Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.

Authors:  Daniel J Boffa; Ryon P Graf; Michelle C Salazar; Jessica Hoag; David Lu; Rachel Krupa; Jessica Louw; Lyndsey Dugan; Yipeng Wang; Mark Landers; Mahipal Suraneni; Stephanie B Greene; Marisa Magaña; Samir Makani; Lyudmila Bazhenova; Ryan V Dittamore; Jorge Nieva
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-26       Impact factor: 4.254

3.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 4.  Circulating tumor cell technologies.

Authors:  Meghaan M Ferreira; Vishnu C Ramani; Stefanie S Jeffrey
Journal:  Mol Oncol       Date:  2016-01-28       Impact factor: 6.603

5.  Biophysical isolation and identification of circulating tumor cells.

Authors:  James Che; Victor Yu; Edward B Garon; Jonathan W Goldman; Dino Di Carlo
Journal:  Lab Chip       Date:  2017-04-11       Impact factor: 6.799

6.  Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer.

Authors:  Marcilei Ec Buim; Marcello F Fanelli; Virgilio S Souza; Juliana Romero; Emne A Abdallah; Celso Al Mello; Vanessa Alves; Luciana Mm Ocea; Natália B Mingues; Paula Nvp Barbosa; Chiang J Tyng; Rubens Chojniak; Ludmilla Td Chinen
Journal:  Cancer Biol Ther       Date:  2015-08-07       Impact factor: 4.742

7.  Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer.

Authors:  Colin M Court; Jacob S Ankeny; Shonan Sho; Shuang Hou; Qingyu Li; Carolyn Hsieh; Min Song; Xinfang Liao; Matthew M Rochefort; Zev A Wainberg; Thomas G Graeber; Hsian-Rong Tseng; James S Tomlinson
Journal:  J Mol Diagn       Date:  2016-07-01       Impact factor: 5.568

Review 8.  Circulating tumor cell isolation: the assets of filtration methods with polycarbonate track-etched filters.

Authors:  Claire Dolfus; Nicolas Piton; Emmanuel Toure; Jean-Christophe Sabourin
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

9.  Circulating Tumor Cells: Who is the Killer?

Authors:  Patrizia Paterlini-Bréchot
Journal:  Cancer Microenviron       Date:  2014-12-20

10.  Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion.

Authors:  Ludmilla T Domingos Chinen; Celso A Lopes Mello; Emne Ali Abdallah; Luciana Mm Ocea; Marcilei E Buim; Natália M Breve; José Luiz Gasparini; Marcello F Fanelli; Patrizia Paterlini-Bréchot
Journal:  Onco Targets Ther       Date:  2014-09-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.